These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12087418)

  • 21. [Micro-RNAs--a new way to regulate protein synthesis].
    Immonen T; Sariola H
    Duodecim; 2002; 118(7):661-2. PubMed ID: 12238175
    [No Abstract]   [Full Text] [Related]  

  • 22. DNA events. An RNA microcosm.
    Baulcombe D
    Science; 2002 Sep; 297(5589):2002-3. PubMed ID: 12242426
    [No Abstract]   [Full Text] [Related]  

  • 23. The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA.
    Ma J; Rong L; Zhou Y; Roy BB; Lu J; Abrahamyan L; Mouland AJ; Pan Q; Liang C
    Virology; 2008 May; 375(1):253-64. PubMed ID: 18289627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication.
    Rasool ST; Tang H; Wu J; Li W; Mukhtar MM; Zhang J; Mu Y; Xing HX; Wu J; Zhu Y
    Immunol Lett; 2008 May; 117(2):161-7. PubMed ID: 18329725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. StpC-based gene therapy targeting latent reservoirs of HIV-1.
    Turner LS; Tsygankov AY; Henderson EE
    Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of drug-resistant HIV-1 by RNA interference.
    Huelsmann PM; Rauch P; Allers K; John MJ; Metzner KJ
    Antiviral Res; 2006 Jan; 69(1):1-8. PubMed ID: 16290277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1.
    Dulude D; Berchiche YA; Gendron K; Brakier-Gingras L; Heveker N
    Virology; 2006 Feb; 345(1):127-36. PubMed ID: 16256163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
    Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
    J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of the host factors necessary for HIV-1 replication--an evaluation through experimental fusion of HIV-1-infected rat cells and human cells].
    Hokkaido Igaku Zasshi; 2005 Jul; 80(4):403-11. PubMed ID: 16107055
    [No Abstract]   [Full Text] [Related]  

  • 30. RNA interference--a new weapon against HIV and beyond.
    Kitabwalla M; Ruprecht RM
    N Engl J Med; 2002 Oct; 347(17):1364-7. PubMed ID: 12397198
    [No Abstract]   [Full Text] [Related]  

  • 31. RNA interference and HIV-1 infection.
    Kanzaki LI; Ornelas SS; Argañaraz ER
    Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
    Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J
    Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of upstream U3 sequences in HIV-1 replication and CD4+ T cell depletion in human lymphoid tissue ex vivo.
    Münch J; Rajan D; Rücker E; Wildum S; Adam N; Kirchhoff F
    Virology; 2005 Oct; 341(2):313-20. PubMed ID: 16102792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA interference: a promising approach to antiviral therapy?
    Silva JM; Hammond SM; Hannon GJ
    Trends Mol Med; 2002 Nov; 8(11):505-8. PubMed ID: 12421679
    [No Abstract]   [Full Text] [Related]  

  • 36. Micro RNA like inhibition of HIV-1 replication.
    Kato K; Habu Y; Takaku H
    Nucleic Acids Symp Ser (Oxf); 2008; (52):509-10. PubMed ID: 18776477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 replication by novel multitarget ribozymes.
    Chen CJ; Banerjea AC; Haglund K; Harmison GG; Schubert M
    Ann N Y Acad Sci; 1992 Oct; 660():271-3. PubMed ID: 1340132
    [No Abstract]   [Full Text] [Related]  

  • 38. Generation of HIV-1 derived lentiviral vectors.
    Follenzi A; Naldini L
    Methods Enzymol; 2002; 346():454-65. PubMed ID: 11883085
    [No Abstract]   [Full Text] [Related]  

  • 39. Interfering with HIV therapy.
    Lund AW
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053154
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research and advancement of RNA].
    Xian XH; Hu JS; Yang ZM; Wang YL; Si LS
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):276-8. PubMed ID: 14518439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.